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Abstract: Limited information indicates that the regulatory factor X1 (RFX1), the prototype member of the
transcription factor RFX family, may play a role in the central nervous system. Our recent study showed that
knockout of the Rfx1 gene led to early embryonic death. In the present study, we showed that heterozygous
Rfx1+/– mice were fertile and grew normally. An abundant amount of RFX1 proteins were expressed in the
olfactory bulb, hippocampus and cerebral cortex as detected by b-galactosidase staining (the gene knockout
vector contained a coding region for b-galactosidase) and immunofluorescent staining with an anti-RFX1 anti-
body. RFX1 positive immunostaining was mainly in the nuclei of neurons and microglial cells and was absent
from the astrocytes of mouse brains. The heterozygous Rfx1+/– mice expressed RFX1 mRNA and proteins at
a level similar to that in the wild-type mice in the olfactory bulb and hippocampus. The expression level of RFX1
proteins was similar in the brains of mice ranging from 15 day old embryos to four month old adults. Our results
suggest a significant expression of RFX1 proteins in the mammalian brain. This expression is cell-type and
brain-region specific and may take a random monoallelic expression pattern. (Folia Histochemica et Cytobio-
logica 2011; Vol. 49, No. 2, pp. 344–351)
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Introduction
The regulatory factor X (RFX) proteins are unique
transcription factors that contain a highly conserved
76-amino acid DNA binding domain. This domain can
bind X-box consensus sequences in the promoter re-
gions of various genes [1]. Seven RFX proteins
(named RXF1-7) have been identified to date in mam-
mals [2]. Their functions are beginning to be under-
stood. For example, RFX5 can regulate the expres-
sion of the major histocompatibility complex class II
genes [3] and knockout of Rfx3 gene causes severe
ciliopathies leading to diabetes and left-right asym-
metry specification [4, 5].
RFX1 is the prototype member of the RFX fami-
ly. Our recent study showed that knockout of the Rfx1
gene in mice leads to early embryonic lethality [6],
suggesting an essential role of RFX1 in early embry-
onic development/survival. Knockout of Rfx homolog
in Caenorhabditis elegans and Drosophila results in
severe sensory defects [7, 8]. Of the mammalian or-
gans and tissues examined, the highest expression level
of RFX1 mRNA is in the brain [2]. We have also
shown that RFX1 proteins are expressed in the neu-
rons of rat brain and can regulate the expression of
the neuronally expressed glutamate transporter type
3 [9]. These results suggest an important role for
RFX1 in the central nervous system. However, no
detailed study on the RFX1 expression profile in the
brain has yet been reported. As an first step to un-
derstanding the biological function of RFX1 in mam-
malian brains, we studied the expression of RFX1
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proteins in the mouse brain. We used the RFX1 mu-
tant mice generated in our previous study [6] to take
advantage of the fact that RFX1 expression can be stud-
ied not only by routine techniques such as Western blot-
ting, but also by LacZ (b-galactosidase) staining, be-
cause those mice have a b-galactosidase gene whose
expression is under the control of Rfx1 promoter.
Material and methods
Animals. As previously described [6], RFX1 mutant mice
were generated using the gene trap technique with the em-
bryonic stem cell clone RRO347 [Rfx1Gt(RRO347)Byg]. The gene
trap vector was pGT2Lxf that contained a coding region for
LacZ and was inserted into the intron sequence between
the exon 2 and exon 3. The mice produced were on C57Bl/
/6J × 129 gene background and were genotyped by poly-
merase chain reaction (PCR) at the age of 18 days. The
Rfx1+/– mice were mated and the wild-type Rfx1+/+ and het-
erozygous Rfx1+/– offspring of the third and fourth genera-
tions were used in this study.
Weighing. Four litters of mice including 15 heterozygous
Rfx1+/– and nine wild-type Rfx1+/+ mice were weighed at
the ages of one, four, seven, 21, 35 and 60 days. The mice
were returned to the cages with their mothers immediately
after weighing.
Brain sectioning. Ten seven-week old heterozygous Rfx1+/–
mice were euthanized using isoflurane and transcardially
perfused by cold normal saline. For immunofluorescent
staining, the mice (five of them) were then perfused with
4% paraformaldehyde in 0.1 M phosphate-buffered saline
(PBS, pH = 7.4) and the brains were post-fixed in 4%
paraformaldehyde in PBS for 24 hours at 4°C. The brains that
were fixed by paraformaldehyde (for immunofluorescent stain-
ing) or were not exposed to paraformaldehyde (for b-galac-
tosidase staining, five mice) were immersed sequentially in 10%,
20%, and 30% sucrose-phosphate buffer solution. Finally,
14 μm-thick cryostat coronal sections were obtained for b-ga-
lactosidase staining or immunofluorescent staining.
b-galactosidase staining. b-galactosidase staining was per-
formed using the b-Gal Staining Kit (Invitrogen, Carlsbad,
CA, USA) according to the manufacturer’s instructions with
minor modifications. Briefly, brain sections were fixed with
a fixative solution containing 2% formaldehyde and 0.2%
glutaraldehyde in PBS for ten minutes at room tempera-
ture. After being rinsed twice, staining solution was added
to the sections and incubated for two hours at 37°C, and
then at 4°C overnight.
Immunofluorescent staining. Antigen retrieval with mi-
crowave heating for 15 minutes in 10 mM tri-sodium citrate
buffer (pH = 6.0) containing 0.05% tween-20 was performed
as described previously [10, 11]. After being cooled at room
temperature, the sections were blocked with 5% donkey
serum in PBS containing 0.1% triton-X 100 and 0.05%
tween-20. For single- or double-labeled immunofluorescent
staining, the following primary antibodies were used: rab-
bit polyclonal anti-RFX1 (1:200, Santa Cruz Biotechnolo-
gy, Santa Cruz, CA, USA); mouse monoclonal anti-micro-
tubule-associate protein 2 (MAP2) (1:1,000; Abcam, Cam-
bridge, MA, USA); rat monoclonal anti-cluster of differen-
tiation molecule 11b (CD11b) (1:100; Abcam); and mouse
monoclonal anti-glial fibrillary acidic protein (GFAP) (1:600;
Millipore, Billerica, MA, USA). After being incubated with
the primary antibodies at 4°C overnight, the Cy3-conjugat-
ed goat polyclonal anti-rabbit serum (1:100, Abcam) or Al-
exa Flour 488-labeled goat anti-mouse/rat serum second-
ary antibody (1:1,000, Invitrogen, Carlsbad, CA, USA) was
applied for one hour at room temperature. Negative con-
trol sections were incubated with PBS as a substitute for
primary antibody.
Western blotting. Each of the seven week-old heterozy-
gous mice was gender-matched with a wild-type mouse from
the same litter. These heterozygous Rfx1+/– and wild-type
Rfx1+/+ mice were euthanized using isoflurane and transcar-
dially perfused by cold normal saline. Their olfactory bulbs
and hippocampi were harvested. Total lysates of these brain
regions (50 μg proteins per lane) were subjected to West-
ern analysis as described previously [12]. The primary anti-
bodies used were the rabbit polyclonal anti-RFX1 antibody
(1:5,000 dilution, a gift from Dr. Patrick Hearing, State
University of New York at Stony Brook, NY, USA) and the
rabbit polyclonal anti-actin antibody (1:5,000 dilution; cat-
alog number: A2066; Sigma Chemical, St. Louis, MO, USA).
The protein bands were visualized using enhanced chemi-
luminescence methods. Quantitative analysis of the protein
bands was performed using an ImageQuant 5.0 GE Health-
care Densitometer (GE Healthcare, Sunnyvale, CA, USA).
The densities of RFX1 protein bands were normalized to
those of actin in the same sample to control for errors in
protein sample loading and transferring during Western
analysis. The result for each mouse was then normalized by
the mean values of wild-type mice in the same experiments.
To determine the developmental brain expression profile
of RFX1, cerebral hemispheres were harvested from wild-
-type C57Bl/6J mouse (Charles River Laboratories; Wilm-
ington, MA, USA) embryos at embryonic day 15. Hippo-
campi were also harvested from one week, one month or
four month old wild-type C57Bl/6J mice. These brain tis-
sues were subjected to Western blotting to determine RFX1
protein expression.
Real-time PCR. Real-time PCR was performed as de-
scribed previously [13]. Total RNA was extracted from the
olfactory bulbs and hippocampi of mice aged seven weeks
using an RNeasy micro kit (Qiagen, Valencia, CA, USA).
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As with Western blotting, littermates of the heterozygous
and wild-type mice that were gender-matched were used in
this study. Primers for real-time PCR were designed based
on the reported sequence of mouse Rfx1 gene using the
Primer Express 3.0 software (Applied Biosystems, Carls-
bad, CA, USA) and selected to best fit the requirement of
SYBR Green assays. The sequences of the primers are: for-
ward, AGTGAGGCTCCACCACTGGCCG and reverse,
TGGGCAGCCGCTTCTC. The sequences corresponding
to these two primers in the Rfx1 gene are in exon 14 and
exon 15, respectively. Quantitative PCRs were carried out
in triplicate using each cDNA sample that was equivalent
to 50 ng of starting total RNA. Amplifying PCR and moni-
toring of the fluorescent emission in real-time were per-
formed in the ABI Prism 7900HT Sequence Detection Sys-
tem (Applied Biosystems, Foster City, CA, USA). To verify
that only a single PCR product was amplified per transcript,
dissociation curve data was analyzed using 7900HT Se-
quence Detection software. To account for possible differ-
ences in starting material, quantitative PCR of the house-
keeping genes glyceraldehydes-3-phosphate dehydrogena-
se and actin was also carried out for each cDNA sample.
The relative amount of RFX1 mRNA in each sample was
determined using the comparative threshold cycle method
and then normalized to those of housekeeping genes.
Statistical analysis. Western blotting and real-time PCR
results were presented as means ± SD and analyzed by
t-test. A p ≥ 0.05 was accepted as significant.
Results
The heterozygous Rfx1+/– mice appeared normal.
Their growth curve overlapped with that of the wild-
-type mice (Figure 1), suggesting that there was no
growth retardation in the heterozygous Rfx1+/– mice.
Since the b-galactosidase expression in the het-
erozygous Rfx1+/– mice is under the control of the
Rfx1 promoter, the expression of b-galactosidase re-
flects the specific expression of RFX1. Brain sections
from each of the five heterozygous Rfx1+/– mice that
were used to cut sections all were b-galactosidase
staining positive. b-galactosidase staining was promi-
nent in the olfactory bulb, cerebral cortex and hip-
pocampus. A significant amount of b-galactosidase
staining also appeared in the striatum (Figure 2).
These brain regions were positively stained by immu-
nofluorescent cytochemistry with the anti-RFX1 an-
tibody (Figure 3).
To identify cell-type origin of RFX1 proteins, we
used double-labeled immunofluorescent staining. As
shown in Figure 4, the RFX1 positive staining is co-
localized with the staining of MAP2, a neuronal spe-
cific protein, and CD11b, a microglial cell-specific
protein. These results suggest that RFX1 is expressed
in the neurons and microglial cells. The RFX1 posi-
tive staining was not co-localized with GFAP, an as-
trocyte-specific protein. In addition, the RFX1 posi-
tive staining mainly appeared in the nuclei of neu-
rons and microglial cells (Figure 4).
Quantitative determination of RFX1 expression
was performed in the olfactory bulb and hippocam-
pus because these two brain structures expressed
a significant amount of RFX1 proteins, as described
above. Also, these two structures represent function-
al diversity of the brain: the olfactory bulb is involved
in the sensory neurotransmission of smell, and the
hippocampus plays an important role in learning and
memory. There was no statistically significant differ-
ence in RFX1 mRNA and protein expression in the
olfactory bulbs and hippocampi between the seven
week old heterozygous Rfx1+/– mice and the wild-type
mice (Figure 5). There was also no evidence of gen-
der difference in RFX1 protein expression. For ex-
ample, the relative RFX1 protein levels after being
normalized by the results of actin were 1.02 ± 0.26
and 0.98 ± 0.22 (arbitrary unit), respectively, in the
hippocampi of male and female wild-type mice aged
seven weeks (p = 0.827, n = 4). In addition, there
was no significant change in RFX1 protein expres-
sion in the brain tissues of the wild-type C57Bl/6J mice
that ranged from 15 day old embryos to four month
old adult mice (Figure 6), suggesting that RFX1 is
maintained at a stable level throughout the period
from late embryonic stage to adulthood.
Discussion
The mouse Rfx1 gene has 21 exons that produce
a protein containing 963 amino acids [14]. The inser-
Figure 1. Weights of the heterozygous Rfx1+/– and
wild-type littermates. Results are means ± SD (n = 15 for
the heterozygous [ten females/five males] and n = 9 for
the wild-type mice [five females/four males])
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Figure 2. b-galactosidase staining of the heterozygous Rfx1+/– mouse brain sections. The brain sections are arranged
from rostrum to caudum in the order of panel A to panel D. Positive staining of b-galactosidase is blue and is pointed by
an arrow. The arrow in panel A indicates anterior olfactory nucleus. The arrows in panel B indicate cerebral cortex and
caudate putamen, respectively. The arrows in panels C and D indicate cerebral cortex and hippocampus, respectively
Figure 3. Immunofluorescent staining of heterozygous Rfx1+/– mouse brain sections with an anti-RFX1 antibody. Positive
staining, in red fluorescence, is shown in the olfactory bulb (A), striatum (B), cerebral cortex (C) and hippocampus (D),
and is pointed by an arrow. A triangle in panel B indicates a lateral ventricle
A B
C D
A B
C D
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Figure 4. Immunofluorescent staining of heterozygous Rfx1+/– mouse brain sections. Photographs were taken from
cerebral cortex. RFX1 positive staining is in red fluorescence. Positive immunofluorescent staining for MAP2 (top panel),
CD11b (middle panel) and GFAP (bottom panel) is in green fluorescence. There are three small panels in each large
panel. Panel A shows positive staining for RFX1 proteins; panel B shows positive staining for MAP2, CD11b or GFAP,
respectively; and panel C is the merged images of panel A and panel B
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tion of the gene trap vector in the embryonic stem
cell clone RRO347A that was used to generate our
mutant mice is in the intron between the exon 2 and
exon 3. This insertion can result in production of
a truncated protein that contains the first 97 amino
acids of the RFX1 protein. Function domains, such
as DNA binding and dimerization domains, that are
important for RFX1 to function as a transcription
factor are in the segments that start after the first 140
amino acids in the molecule [14]. Thus, the truncated
proteins produced in our mutant mice should not have
the functions of RFX1. Consistent with this loss-of-
-function concept, Rfx1 knockout leads to embryon-
ic lethality before the age of 3.5 days [6].
Currently, RFX1 functions are largely unknown.
A few studies have indicated a role of RFX1 in the
central nervous system [7–9]. However, there has only
been one study describing the distribution of RFX1
proteins in mammalian brains [9]. It showed by im-
munocytochemistry that RFX1 proteins were in the
neurons of the cerebral cortex, hippocampus and cer-
ebellum of rats [9]. However, the study did not in-
clude detailed investigation of the brain region dis-
tribution and cell type origin of RFX1 proteins. Our
current study suggests that olfactory bulb and stria-
tum also express RFX1 protein in the mouse. In ad-
dition to neurons, RFX1 proteins are expressed in
microglial cells. Consistent with the nature of tran-
scription factors, the RFX1 proteins were mainly ex-
pressed in the nuclei. Interestingly, RFX1 expression
in the brain does not change significantly from E15
to adult mice. RFX1 has been shown to regulate ex-
pression of early response genes and growth factors
[15, 16]. Our recent study showing embryonic lethal-
ity of Rfx1 knockout suggests a critical role of RFX1
in early embryonic development and cell survival [6].
In addition, we have shown that RFX1 regulates the
expression of glutamate transporter type 3 [9], a neu-
ron-specific glutamate transporter that is involved in
regulating glutamate neurotransmission and learning
Figure 5. RFX1 mRNA and protein expression in the heterozygous Rfx1+/– and wild-type littermates. Each heterozygous
Rfx1+/– mouse was gender-matched with one wild-type mouse from the same litter. Their olfactory bulbs and hippocampi
were isolated for real-time polymerase chain reaction and Western blotting. The relative RFX1 mRNA and protein
abundance after being normalized by the results of actin in the same sample is presented in panel A and panel B, respecti-
vely. The protein results were further normalized by the mean values of wild-type littermates in the same Western blot.
In panel B, a representative Western blot is presented in the left panels and the pooled results are presented as a bar
graph in the right panels. Results are means ± SD (n = 8 for each bar in the pooled results)
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and memory functions [17, 18]. These findings sug-
gest a broad range of functions of RFX1 in neurons.
This suggestion is supported by a ubiquitous expres-
sion pattern of RFX1 in the brain as shown in this study.
A common rule that is generally assumed to con-
trol gene expression in diploid eukaryotic organisms
is that maternally and paternally derived copies of
each gene are simultaneously expressed at similar lev-
els. However, it is well-known that there is a monoal-
lelic expression pattern in which only one of the two
alleles is expressed. Our results suggest that Rfx1 gene
takes a monoallelic expression pattern in the brain
because the heterozygous Rfx1+/– mice had a similar
level of RFX1 mRNA and protein to that of the wild-
-type mice in the olfactory bulbs and hippocampi.
There are three classes of monoallelic expression
patterns [19].
The first class includes X-inactivated genes. Reg-
ulation of RFX1 expression does not belong to this
class because RFX1 gene is in chromosome 19 in
humans and chromosome 8 in mice [20].
Figure 6. RFX1 protein expression in the wild-type
C57Bl/6J mice. Cerebral hemispheres were harvested from
embryos at embryonic day 15 (E15). Hippocampi also were
harvested from one week, one month or four month old
wild-type mice. They then were subjected to Western
blotting. A representative Western blot is presented in the
top panels and the pooled results of the relative RFX1
protein abundance after being normalized by the results of
actin in the same sample, and then the mean values of E15
embryos in the same blot are presented as a bar graph in
the bottom panels. Results are means ± SD (n = 6 for
each bar in the pooled results)
The second class consists of autosomal imprinted
genes whose expression is controlled in a parent-of-
-origin-specific pattern [21]. Our previous study
showed that knockout of Rfx1 gene expression leads
to early embryonic death and the ratio of the wild-
-type mice to the heterozygous Rfx1+/– mice in the
living mice of our large sample (154 mice) was about
1:2 [6]. If Rfx1 expression takes the form of imprint-
ing to regulate its expression, and this reprinting oc-
curs very early in the embryonic development, we
would expect a 1:1 ratio of the living heterozygous
Rfx1+/– mice to the wild-type mice. If this reprinting
happens later, we would expect that some of the het-
erozygous Rfx1+/– mice do not express RFX1 proteins.
We examined RFX1 protein expression in the hip-
pocampus and olfactory bulb by Western blotting. All
of the heterozygous Rfx1+/– mice expressed RFX1 in
these two brain regions, and all five heterozygous
Rfx1+/– mice whose brains were sectioned were b-ga-
lactosidase staining positive. Thus, RFX1 expression
may not be regulated by reprinting in the brain.
The third and final class of monoallelic expres-
sion is the random monoallelic expression of autoso-
mal genes [19]. This group of genes takes a random
form to control their gene expression: some cells ex-
press the maternal allele, and other cells express the
paternal allele. In some cases/genes, cells express both
alleles. The heterozygous Rfx1+/– mice and the wild-
-type mice expressed a similar level of RFX1 mRNA
and proteins in the hippocampus and olfactory bulb,
and the brain regional distribution of RFX1 proteins
and b-galactosidase is very similar in the brains of the
heterozygous Rfx1+/– mice. Thus, RFX1 expression
may take the form of random monoallelic expres-
sion in which cells express products from both alle-
les. However, our results cannot completely exclude
the possibility that RFX1 expression takes a biallel-
ic pattern. The evidence to support this pattern is
our finding that both alleles are expressed. Although
a similar level of RFX1 in the heterozygous Rfx1+/–
and wild-type littermates does not support the bial-
lelic expression pattern, this finding could be due to
the results of compensatory mechanisms to main-
tain a critical level of RFX1 in the heterozygous
Rfx1+/– mice.
We have observed that the heterozygous Rfx1+/–
mice appeared normal and did not have growth re-
tardation. These findings are consistent with our re-
sults that the heterozygous Rfx1+/– mice did not have
a significant change in the RFX1 protein expression
in their brains.
In summary, we have shown that RFX1 proteins
are abundantly expressed in the hippocampus, cere-
bral cortex and olfactory bulb, and are also expressed
in the striatum. The heterozygous Rfx1+/– mice have
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a similar level of RFX1 mRNA and proteins to that
of the wild-type mice in the olfactory bulbs and hip-
pocampi. These proteins are mainly expressed in the
nuclei of neurons and microglial cells. These results,
along with our previous findings that RFX1 is critical
for embryonic development/survival and that the ra-
tio of the living heterozygous Rfx1+/– mice to the wild-
-type mice is about 2:1 [6], suggest that Rfx1 takes
the form of random monoallelic expression pattern
to regulate its expression.
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